MA5-24942

antibody from Invitrogen Antibodies

Targeting: TRIB2 GS3955, TRB2

Western blot (Data presented on provider website)

Immunocytochemistry (Supportive data in Antibodypedia)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Recommended by provider)

Other assay (Supportive data in Antibodypedia)

Antibody Data

Product number

MA5-24942

Provider

Invitrogen Antibodies

Product name

TRIB2 Monoclonal Antibody (OTI8D11)

Antibody type

Monoclonal

Antigen

Recombinant full-length protein

Reactivity

Human

Host

Mouse

Isotype

IgG

Antibody clone number

OTI8D11

Vial size

100 µL

Concentration

1 mg/mL

Storage

-20° C, Avoid Freeze/Thaw Cycles

References

Submitted references

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.

Wang J, Zuo J, Wahafu A, Wang MD, Li RC, Xie WF
CNS neuroscience & therapeutics 2020 Mar;26(3):297-308

Immunocytochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunofluorescent analysis of TRIB2 in COS7 cells. Cells were probed with a TRIB2 monoclonal antibody (Product # MA5-24942).

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Figure 5 Representative IHC images of TRIB2 and MAP3K1 in glioma samples. Upper panel: H&E staining; second panel: TRIB2 staining; third panel: MAP3K1 staining; lower panel: presurgical dynamic contrast-enhanced scanning. Brain tissue from epilepsy surgery was used as a negative control